Description
Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH) and is studied for its ability to stimulate endogenous growth hormone secretion and increase circulating IGF-1 levels. It has attracted particular research interest in body-composition, metabolic and growth-hormone signalling studies.
Areas of Research Interest
Tesamorelin is being investigated for potential effects on:
- Growth hormone and IGF-1 signalling
- Visceral fat and body-composition changes
- Lipid and glucose metabolism
- Protein metabolism and tissue-remodelling pathways
- Metabolic health and endocrine function
Unlike longer-acting CJC-1295 with DAC, Tesamorelin is a GHRH analogue with a more defined pharmacological profile and has been studied clinically in specific medical populations, particularly in relation to visceral adipose tissue.
Tides Tesamorelin is supplied as a lyophilised research-grade powder, with independent batch testing used to verify identity and purity.
Product information:
- Tesamorelin
- GHRH analogue
- Lyophilised powder
- Purity >99%
- Independently batch tested
- Certificate of Analysis available
- UK dispatched
- For research use only
Reviews
There are no reviews yet.